Introduction {#s1}
============

It has been well demonstrated that gastric cancer is the second leading cause of cancer related death and the fourth most common malignancy, which accounts for 9.7% of total cancer deaths worldwide \[[@B1]\]. As a major public health challenge, it is reported that about one million new cases of gastric cancer were diagnosed in 2008. However, the mechanism of gastric carcinogenesis is still not fully understood. Current evidence suggests that, in combination with environmental factors, low-pentrance susceptibility genes play an important role in the development of cancer \[[@B2]\].

Human glutathione S-transferases (GSTs) are phase II metabolizing enzymes that are critical for protection from cancer by detoxifying numerous potentially cytotoxic or genotoxic compounds \[[@B3]\]. According to their amino acid sequence, immunological cross-reactivity, and substrate specificity, human cytosolic GSTs have been classified into seven families, namely GST alpha, mu, pi, sigma, omega, theta, and zeta \[[@B4],[@B5]\]. Glutathione S-transferase M1 (GSTM1), belonging to the GST mu gene family, is polymorphic and the common deletion polymorphism of GSTM1 has been extensively studied. The homozygous deletion of GSTM1 gene lead to total absence of GSTM1 enzyme activity. It was reported that the deleted GSTM1 genotype was in high percentage of human population, about 40-60% in Europeans \[[@B6]\] and about 50% in Asians \[[@B7]\].

A lot of epidemiological studies have investigated the association of GSTM1 depletion with risk of gastric cancer and several meta-analyses have been performed to clarify this issue \[[@B5],[@B8],[@B9]\]. The most recent meta-analysis was conducted in 2010 \[[@B1],[@B6]\], as well as several other similar meta-analyses and a lot of studies with larger sample size have been published \[[@B10]-[@B12]\]. However, limited by number of studies, previous studies failed to assess the influence of some important factors, like Helicobacter pylori infection, the well established risk factor of gastric cancer, smoking status, location of tumor, and sample size \[[@B5],[@B8]\].

Thus, we conducted an updated meta-analysis to comprehensively assess the relationship between GSTM1 deletion polymorphism and risk of gastric cancer and evaluate the influence of confounding factors

Materials and Methods {#s2}
=====================

Identification of eligible studies {#s2.1}
----------------------------------

This study was carried out and reported in agreement with the PRISMA guidelines for systematic reviews and meta-analyses \[[@B13]\] (supplementary information: [Checklist S1](#pone.0081403.s001){ref-type="supplementary-material"}. PRISMA checklist). Eligible case-control studies were extracted by searching databases and manual search of references of relative articles and reviews. A comprehensive literature search was carried out using electronic databases of PubMed and EMBASE. To avoid selection bias, Chinese databases like China National Knowledge Infrastructure (CNKI) was not searched. The following medical subheadings (MeSH) and key words were utilized during database searching: "glutathione S-transferase M1" or "GSTM1", "polymorphisms, single nucleotide" or "polymorphism", and "stomach neoplasms" or "gastric cancer". Alternative spellings of these key words were also considered. There was no limitation of research and the last research was performed on August 12, 2013. References of related studies and reviews were manually searched for additional studies.

Inclusion and exclusion criteria {#s2.2}
--------------------------------

Studies were selected according to the following inclusion criteria: (1) case-control studies; (2) investigating the association between GSTM1 deletion polymorphism and gastric cancer risk; (3) with available genotype distribution data to calculate combined odds ratios (ORs) and 95% confidence intervals (95% CIs). Studies without detail genotype distribution data were excluded. Titles and abstracts of searching records were primarily screened and full text papers were further retrieved to confirm eligibility. Two reviewers (ZY and DX) extracted eligible studies independently according to the inclusion criteria. Disagreement between two reviewers was discussed with another reviewer (SGQ) till consensus was achieved.

Data extraction {#s2.3}
---------------

Data of eligible studies was extracted by two reviewers (ZY and DX) independently with a pre-designed data-collection form. The following data was collected: name of first author, year of publication, country where the study was conducted, ethnicity, source of control, number of cases and controls, genotype frequency in cases and controls, H. pylori infection (positive and negative), smoking status (ever-smoker and non-smoker), tumor location (cardia and non-cardia), and Lauren's classification (diffuse and intestinal). Different ethnicity descents were categorized as Asian, Caucasian, and Latin American. For H. pylori infection and smoking status, we collected data according the original definition of eligible studies and no modification or adjustment was performed. Eligible studies were defined as hospital-based (HB) and population-based (PB) according to the control source. Two reviewers reached consensus on each item.

Statistical analysis {#s2.4}
--------------------

The association strength between GSTM1 null genotype and gastric cancer risk was measured by OR with 95% CI. The estimated ORs were achieved by pooling genotype distribution data from each eligible study. A 95% CI was used for statistical significance test and a 95% CI without 1 for OR indicating a significant increased or reduced cancer risk. The pooled ORs were calculated for the comparison of null genotype versus present genotype. Subgroup analyses were also conducted to explore the effects of confounding factors: ethnicities, sources of control, sample size, H. pylori infection, smoking status, location, and Lauren's classification.

Chi-square based Q test was used to check the statistical heterogeneity between studies, and the heterogeneity was considered significant when p\<0.10\[[@B14]\]. Given the significant heterogeneity and to achieve a conservative estimate, random-effects model (based on DerSimonian-Laird method) were used to pool the data from different studies \[[@B15]\]. Meta-regression was performed to detect the source of heterogeneity and a p\<0.05 was considered significant\[[@B16]\].

Publication bias was detected with Begg's funnel plot and the Egger' linear regression test, and a p \< 0.05 was considered significant\[[@B17]\]. To test the influence of publication bias, fail-safe number for p=0.05 (Nfs~0.05~) and p=0.01 (Nfs~0.01~) was also calculated\[[@B18]\].All statistical analyses were calculated with STATA software (version 10.0; StataCorp, College Station, Texas USA). And all P values were two-side.

Results {#s3}
=======

The detailed process of study selection was shown in [Figure 1](#pone-0081403-g001){ref-type="fig"}. After comprehensive search and rigid selection, 46 eligible studies were identified\[[@B10]-[@B12],[@B19]-[@B61]\]. The genotype distribution data was available for 8138 patients of gastric cancer and 13867 controls. The baseline characteristics of eligible studies were shown in [Table 1](#pone-0081403-t001){ref-type="table"}. 28 studies were carried out in Asian, 16 studies were in Caucasian, and 2 studies were in Latin American. Notably, 32 of 46 studies were of a small sample size and only 14 studies included more than 500 participants.

![Flow chart of study selection.](pone.0081403.g001){#pone-0081403-g001}
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###### Baseline characteristics of eligible studies.

  Author               Year   Country    Ethnicity       Source   Cases   Controls   Case   Control         
  -------------------- ------ ---------- --------------- -------- ------- ---------- ------ --------- ----- -----
  Kato S               1996   Japan      Asian           HB       81      151        30     34        61    59
  Katoh T              1996   Japan      Asian           HB       139     126        79     60        55    71
  Alves GM             1998   Portugal   Caucasian       HB       148     84         71     77        44    40
  Oda Y                1999   Japan      Asian           HB       147     112        91     56        55    57
  Cai L                2001   China      Asian           PB       95      94         60     35        43    51
  Saadat I             2001   Iran       Asian           PB       42      131        26     16        53    78
  Setiawan VW^a^       2001   China      Asian           PB       133     433        40     39        202   205
  Shen J               2001   China      Asian           PB       112     675        71     41        361   314
  Gao CM               2002   China      Asian           PB       153     223        95     63        133   90
  Sgambato A           2002   Italy      Caucasian       HB       8       100        5      3         53    47
  Wu MS                2002   China      Asian           HB       356     278        173    183       136   142
  Colombo J^a^         2004   Brazil     Latin America   HB       100     150        47     53        62    88
  Roth MJ              2004   China      Asian           PB       90      454        24     66        145   309
  Suzuki S             2004   Japan      Asian           HB       146     177        87     58        84    93
  Torres MM            2004   Colombia   Latin America   HB       46      96         30     16        36    60
  Lai KC               2005   China      Asian           HB       123     121        73     50        55    66
  Li H                 2005   Chian      Asian           HB       102     62         67     33        26    36
  Nan HM               2005   Korea      Asian           HB       110     220        73     34        130   90
  Palli D              2005   Italy      Caucasian       PB       175     546        90     85        275   271
  Shen J               2005   China      Asian           PB       114     693        71     41        361   314
  Tamer L              2005   Turkey     Caucasian       HB       70      204        40     30        88    116
  Agudo A              2006   UK         Caucasian       PB       243     946        122    120       498   434
  Hong SH              2006   Korea      Asian           HB       108     238        60     48        134   104
  Lee K                2006   Chile      Caucasian       HB       73      263        13     60        56    207
  Martínez C           2006   Spain      Caucasian       PB       98      329        33     54        149   180
  Boccia S             2007   Italy      Caucasian       HB       102     254        59     43        135   119
  Ruzzo A              2007   Italy      Caucasian       HB       126     144        35     44        61    51
  Wideroff L           2007   USA        Caucasian       PB       116     209        61     55        121   87
  Tripathi S^a^        2008   India      Asian           HB       76      100        31     45        39    61
  Al-Moundhri MS       2009   Oman       Caucasian       HB       107     107        42     65        32    75
  Malik MA             2009   India      Asian           HB       108     195        64     44        79    116
  Masoudi M            2009   Iran       Caucasian       PB       67      134        37     30        60    74
  Moy KA               2009   China      Asian           PB       307     911        98     72        415   320
  Piao JM              2009   Korea      Asian           PB       2213    1699       1225   988       923   776
  Zendehdel K          2009   Sweden     Caucasian       PB       126     471        70     54        239   230
  Nguyen TV            2010   Vietnam    Asian           HB       59      109        43     16        75    34
  Palli D              2010   Italy      Caucasian       PB       314     548        166    130       275   271
  Yadav DS             2010   India      Asian           HB       133     270        49     84        120   150
  Darazy M             2011   Lebanese   Caucasian       PB       13      70         6      7         12    58
  Luo YP               2011   China      Asian           PB       123     129        93     50        71    58
  Yadav D              2011   India      Asian           PB^b^    41      130        11     30        38    92
  Zhang AP             2011   China      Asian           PB       194     412        105    89        194   218
  García-González MA   2012   Spain      Caucasian       PB       557     557        284    273       267   290
  Jing C               2012   China      Asian           HB       410     410        240    170       207   203
  Kim HJ               2012   Korea      Asian           HB       102     200        61     41        124   76
  Malakar M            2012   India      Asian           PB       102     204        57     45        97    107

PB: population-based; HB: hospital-based; a: only genotype data of healthy controls were extracted; b: source of controls were not described and the study was assumed as PB

Overall analysis {#s3.1}
----------------

All meta-analysis results were shown in [Table 2](#pone-0081403-t002){ref-type="table"}. By pooling all 46 eligible studies, we found the GSTM1 null genotype was associated with a significantly increased risk of gastric cancer (OR=1.217, 95% CI: 1.113-1.331, P~heterogeneity~\<0.001; [Figure 2](#pone-0081403-g002){ref-type="fig"}). Since significant heterogeneity existed, meta-regression was performed to detect the source of heterogeneity and the results suggested that ethnicities (p\<0.001), source of control(p\<0.001), and sample size (p\<0.001) contributed to the heterogeneity. Egger's test (p=0.02) and Begg's test (p=0.003) found the evidence of publication bias ([Figure 3](#pone-0081403-g003){ref-type="fig"}). However, the fail-safe-number was large (Nfs~0.05~=1299.9, Nfs~0.01~=602.8), which suggested that the publication bias was feeble and our result is solid.

10.1371/journal.pone.0081403.t002

###### Meta-analysis results of GSTM1 polymorphism and gastric cancer risk.

  comparison                No. of Studies   OR (95% CI)              Heterogeneity
  ------------------------- ---------------- ------------------------ ---------------
  Overall                   46               1.217 (1.113-1.331)\*    p\<0.001
  Source of Control                                                   
  Hospital-Based            24               1.283 (1.104-1.490) \*   0.002
  Population-Based          22               1.156 (1.041-1.284) \*   0.041
  Enthnicity                                                          
  Asian                     28               1.273 (1.137-1.426) \*   0.002
  Caucasian                 16               1.081 (0.941-1.243)      0.094
  Latin American            2                1.906 (0.784-4.630)      0.046
  Sample Size                                                         
  Small                     32               1.296 (1.125-1.494) \*   p\<0.001
  Large                     14               1.120 (1.029-1.220) \*   0.311
  Smoking Status                                                      
  Non-smoker                12               1.777 (1.301-2.426) \*   p\<0.001
  Ever-smoker               11               1.459 (1.024-2.077) \*   0.014
  H. pylori Infection                                                 
  Positive                  3                1.928 (1.028-3.615) \*   0.065
  Negative                  4                0.969 (0.618-1.521)      0.168
  Location of Tumor                                                   
  Cardia                    3                0.904 (0.648-1.261)      0.338
  Non-Cardia                2                1.051 (0.831-1.331)      0.394
  Lauren's Classification                                             
  Diffuse Type              5                1.162 (0.776-1.741)      0.066
  Intestinal Type           5                1.524 (0.998-2.327)      0.017

OR: odds ratio, 95% CI: 95% confidence intervals; p\<0.1 indicates significant heterogeneity; \* significant association

![Overall analysis of GSTM1 null genotype and gastric cancer risk.\
A number of 46 studies were included.](pone.0081403.g002){#pone-0081403-g002}

![Funnel plot for the overall analysis of GSTM1 null genotype and gastric cancer risk.\
Circles represent the weight of each study.](pone.0081403.g003){#pone-0081403-g003}

Sub-group analysis {#s3.2}
------------------

### Ethnicities {#s3.2.1}

Sub-group analysis for ethnicities was performed and the increased risk of gastric cancer was only observed in Asians (OR=1.273, 95%: 1.137-1.426, P~heterogeneity~=0.002), while no significant association was found in Caucasians or Latin Americans ([Figure S1](#pone.0081403.s002){ref-type="supplementary-material"}).

### Source of control {#s3.2.2}

The results showed that source of controls did not affect the pooled results and we observed a significantly increased risk of gastric cancer both in PB and HB studies.

### Sample size {#s3.2.3}

As shown in [Table 1](#pone-0081403-t001){ref-type="table"}, most eligible studies about GSTM1 polymorphism and gastric cancer were small-sized (less than 500 participants). The mean number of participants for "small studies" was 252 and the mean for "large studies" was 964. Sub-group analysis revealed that the pooled results did not differ between large studies and small studies, since increased susceptibility was observed in both sub-groups ([Table 2](#pone-0081403-t002){ref-type="table"}).

### Helicobacter pylori infection {#s3.2.4}

HP infection is a well known risk factor of gastric cancer and 4 studies provided data about HP infection status and GSTM1 genotype distribution. As shown in [Table 2](#pone-0081403-t002){ref-type="table"}, the null genotype of GSTM1 was associated with an elevated risk of gastric cancer in the HP positive sub-group (OR=1.928, 95% CI: 1.028-3.615, P~heterogeneity~=0.065), while no significant association was found in the HP negative sub-group (OR=0.969, 95% CI: 0.618-1.521, P~heterogeneity~=0.168).

### Smoking status {#s3.2.5}

Smoking is a risk factor of various kinds of cancer, including gastric cancer, and GST family is also involved in the metabolism of various carcinogens in cigarette smoke. As shown in [Table 2](#pone-0081403-t002){ref-type="table"}, data of smoking status and GSTM1 genotype distribution were available in 12 studies. Sub-group analysis results suggested that there was no difference of gastric cancer risk between ever-smokers and non-smokers, because significantly increased risk was found in both sub-groups ([Figure 4](#pone-0081403-g004){ref-type="fig"}).

![Sub-group analysis of smoking status (ever-smoker and non-smoker).](pone.0081403.g004){#pone-0081403-g004}

### Location and Lauren's classification {#s3.2.6}

We also performed stratified analyses according to location of tumor (cardia and non-cardia) and Lauren's classification (diffuse and intestinal). The number of studies available for the sub-group analysis of location was quite small (3 studies), and no significant association of GSTM1 null genotype with gastric cancer risk was observed in neither sub-group ([Table 2](#pone-0081403-t002){ref-type="table"}). As for sub-groups of Lauren's classification, we did not found any significant association for diffuse type cancer or intestinal type cancer.

Discussion {#s4}
==========

Genetic polymorphisms are natural DNA sequence variations and the expected frequency is about 1% among healthy population \[[@B62]\]. Functional genetic polymorphism in the gene regulation region or coding sequences could change gene expression or function. Additionally, genetic polymorphism may, to some degree, explain the inter-individual variation and diversity, and has been recently considered as principal genetic elements involved in the development of cancer \[[@B63]\]. The GST gene family encoding phase II detoxification enzymes is critical for the protection against various chemical carcinogenesis \[[@B3]\]. The GSTM1 enzyme is responsible for the metabolism of reactive electrophilic intermediates, including environmental pollutants and other polycyclic aromatic hydrocarbons, which are potent carcinogenic agents. Thus, impaired GSTM1 function may lead to serious DNA damage and carcinogenesis. Considering that the GSTM1 null genotype caused a complete loss of GSTM1 enzyme activity, it is biologically plausible that the GSTM1 null genotype may increase risk of gastric cancer.

Since the first study in 1991 by Strange and colleagues \[[@B64]\] which reported the association between the GSTM1 null genotype and increased risk of gastric cancer, a lot of epidemiological studies about the relationship between GSTM1 and gastric cancer have been conducted\[[@B23],[@B48],[@B55]\]. Limited by number of studies, the conclusion about GSTM1 null genotype and gastric cancer was still unclear, as well as influence of some important factors like H. pylori infection and smoking status. Since a large number of studies have been published \[[@B10]-[@B12]\], it is necessary to perform an update meta-analysis to assess the association between GSTM1 and gastric cancer and explore the effect of H. pylori infection, smoking, location and Lauren's classification.

In this study, we identified 46 eligible studies, including 8138 gastric cancer cases and 13867 controls, which could provide sufficient statistic power. By pooling all available data, we found the null genotype was associated with a statistically elevated risk of gastric cancer (OR=1.217, 95% CI: 1.113-1.331), which was consistent with previous meta-analyses \[[@B8],[@B65]\]. By stratifying studies according to ethnicities, increased risk of gastric cancer was only observed in Asians and no significant association was found in Caucasians or Latin Americans, which was also in agreement with previous studies. The ethnic difference was common for genetic association studies, which may be due to different genetic background and environmental differences. Additionally, the incidence of gastric cancer is quite heterogeneous in Asia population, and the findings should be explained with caution when applied to a specific area. Notably, heterogeneity was significant in this meta-analysis ([Table 2](#pone-0081403-t002){ref-type="table"}). Meta-regression analysis indicated that ethnicities (p\<0.001), source of control (p\<0.001), and sample size (p\<0.001) were the source of heterogeneity. For source of control, participants from hospital may have different genetic background compared with those from general population. To achieve an acute estimation of the relationship between GSTM1 null genotype and gastric cancer risk, future studies should take these factors into consideration.

Helicobacter pylori, the group I carcinogen classified by World Health Organization, is one of the most important risk factors for gastric cancer\[[@B66]\]. By performing sub-group analysis, we only found the increased risk of gastric cancer in the H. pylori positive group (OR=1.928, 95% CI: 1.028-3.615), while there was no significant association in the H. pylori negative group (OR=0.969, 95% CI: 0.618-1.521). This finding suggested that H. pylori infection could modify the association between GSTM1 polymorphism and susceptibility to gastric cancer \[[@B67]-[@B69]\]. Tobacco smoke contains various carcinogens like N-nitrosamines, polycylic aromatic hydrocarbons, and heterocyclic amines, which require detoxification by different pathways, including GSTs. To assess the influence of smoking, we extracted data from 12 eligible studies and found that smoking status did not alter the relationship between GSTM1 null genotype and risk of gastric cancer. This may be explained by that GSTM1 is just a member of GST family and the null genotype will not significantly impair the overall GST enzyme activity. For location of tumor and Lauren's classification, we did not found any significant association. Given that studies included in these sub-groups were few ([Table 2](#pone-0081403-t002){ref-type="table"}), further studies are warranted.

Compared with previous meta-analysis, we included more studies and performed sub-group analyses to assess the influence of ethnicities, source of controls, sample size, H. pylori infection, smoking, tumor location, and Lauren's classification. Notably, we searched databases of PubMed and EMBASE but not China National Knowledge Infrastructure (CNKI), because CNKI Chinese-language database, which is usually not accessible for non-Chinese researchers. However, limitations of this meta-analysis should be highlighted. First, Egger's test and Begg's test suggested the evidence of publication bias. We calculated the fail-safe number and the number was large enough (Nfs~0.05~=1299.9, Nfs~0.01~=602.8) to provide credence to our results. Secondly, heterogeneity was significant in this study. To achieve a precise and conservative estimation, we used random-effects model to pool eligible studies and meta-regression found that ethnicities, source of control, and sample size were the source of heterogeneity. Thirdly, in the sub-group analysis of location, number of studies was relatively small and the results should be interpreted with caution.

To summary, in this meta-analysis based on 46 epidemiological studies, we show that the GSTM1 null genotype is associated with increased risk of gastric cancer among Asians but not among Caucasians. The null genotype increased susceptibility to gastric cancer both in ever-smokers and non-smokers, while the significant association was only observed in H. pylori positive population.
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